Journal Updates

Type 1 diabetes can be effectively treated with rapid-acting insulin analogues than regular human insulin

Rapid-acting insulin analogues are found to be more effective at reducing postprandial glucose and improving HbA1c than regular human insulin in patients with type 1 diabetes.

The findings of a meta-analysis published in the Diabetes Therapy journal revealed that the difference in postprandial glucose between rapid-acting insulin analogues- and regular human insulin-treated patients was significant-in favour of rapid-acting insulin analogues in patients with type 1 diabetes. Moreover, these agents were also better than regular human insulin in improving HbA1c levels.